Neuroendocrine S2012
Study #S2012Randomized Phase II/III Trial of First Line Platinum / Etoposide with or without Atezolizumab (NSC#783608) in Patients with Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC)
Back To Clinical Trials NCI Database Entry